M1FG
LEGN icon

Mach-1 Financial Group’s Legend Biotech LEGN Stock Holding History

Mach-1 Financial Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,022
Closed -$472K – 252
2023
Q3 		$472K Buy
7,022
+320
+5% +$22.2K 0.2% 140
2023
Q2 		$463K Buy
+6,702
New +$438K 0.13% 157

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mach-1 Financial Group's LEGN Position: Q4 2023 in Review

Mach-1 Financial Group sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 7,022 shares — an estimated $472K sold.

Mach-1 Financial Group first reported a position in LEGN in Q2 2023 and held it in 2 quarters. The position peaked at $472K in Q3 2023. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Mach-1 Financial Group reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Mach-1 Financial Group sold 7,022 Legend Biotech shares in Q4 2023, an estimated $472K.
  • Mach-1 Financial Group first reported a position in Legend Biotech in Q2 2023 and held it in 2 quarters.
  • Mach-1 Financial Group's Legend Biotech position peaked at $472K in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Mach-1 Financial Group's 13F filing for Q4 2023, filed 5 Feb 2024.